http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014050134-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 |
filingDate | 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2014050134-A1 |
titleOfInvention | Dyslipidemia therapeutic agent |
abstract | An object of the present invention is to provide a combination pharmaceutical composition and a medicament for preventing and / or treating dyslipidemic conditions such as atherosclerosis, hypercholesterolemia and hypoHDLemia in mammals including humans. To provide a combination. a) a compound represented by the following general formula (1) (wherein each symbol has the same meaning as described in the specification), or a salt thereof, or a solvate thereof; and b) A pharmaceutical composition for preventing and / or treating dyslipidemia and the like comprising a cholesterol absorption inhibitor. |
priorityDate | 2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.